Alpine Income Property Trust's (NYSE:PINE) total investment activity in 2024, which includes its acquisition and structured ...

Wall Street see-sawed amid choppy trading on Thursday, reversing earlier gains as investors embarked on the new year facing ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

We recently compiled a list of the 10 Best Organic Food and Farming Stocks To Invest In. In this article, we are going to ...

Bob Kaynor, CFA, Head of US Small & Midcap Equities at Schroders, provided a comprehensive outlook for small-cap stocks in ...

Shares of Uber Technologies (UBER) and Norwegian Cruise Lines (NCLH) are higher after Goldman Sachs added them to its January ...

The estimated year-over-year S&P 500 earnings growth rate for 2025 hovers at 14.8 percent, according to FactSet. That’s well above the trailing 10-year average of eight percent, and the bump reflects ...

Johnson & Johnson (NYSE:JNJ – Get Free Report) was the target of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 17,570,000 ...

Alibaba to sell stake in China's hypermarket chain Sun Art. Brand prescription drugs to rise an average 4.5% in 2025.

The Nasdaq 100 is capping off 2024 with a return of 27.0%, building upon 2023’s 53.8% return (its best year since 1999).

These Jefferies Franchise Picks for 2025 look like outstanding ideas for growth and income investors, as they offer reliable ...